Zacks.com Featured Expert Kevin Matras Highlights: Dynex Capital, Hi-Tech
Pharmacal, Owens-Illinois, Tech Data and World Acceptance Corporation
CHICAGO, Jan. 5, 2011
CHICAGO, Jan. 5, 2011 /PRNewswire/ -- Stocks in this week's article include:
Dynex Capital, Inc. (NYSE: DX), Hi-Tech Pharmacal Co. (Nasdaq: HITK),
Owens-Illinois, Inc. (NYSE: OI), Tech Data Corporation (Nasdaq: TECD) and
World Acceptance Corporation (Nasdaq: WRLD). Kevin Matras shows the right way
to find great growth stocks at an excellent value.
Screen of the Week written by Kevin Matras of Zacks Investment Research:
Looking for growth and value is a winning combination. And while there are
still plenty of them around, it's getting harder to find stocks that fit
squarely into both categories.
But I believe there's a right way and wrong way to find both growth and value
stocks. Most will start off with either one or the other. But I do it by using
a uniform ranking on both categories.
And that's the focus of this week's screen. It focuses on companies with the
highest growth rates AND the lowest P/E ratios ALL AT THE SAME TIME. So with
this screen, we're not starting with one and then looking for the other. The
order of the parameters is irrelevant. If I switched it around, I'd get the
That's because essentially I'm demanding that the companies have to have BOTH
growth rates AND valuations in the 80th percentile, i.e., better than 80% of
all the other stocks out there. And better on each category.
For the rest of this Screen of the Week article, please visit Zacks.com at:
Sign up now for your free trial today and start picking better stocks
immediately. And with the backtesting feature, you can test your ideas to see
how you can improve your trading in both up markets and down markets. Don't
wait for the market to get better before you decide to do better. Start
learning how to be a better trader today: http://at.zacks.com/?id=111
Disclosure: Officers, directors and/or employees of Zacks Investment Research
may own or have sold short securities and/or hold long and/or short positions
in options that are mentioned in this material. An affiliated investment
advisory firm may own or have sold short securities and/or hold long and/or
short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the
distinction as the "#1 site for screening stocks" by Money Magazine. But
powerful screening tools is just the start. That is why Zacks created the
Screen of the Week to highlight profitable stock picking strategies that
investors can actively use. Each week, Zacks Profit from the Pros free email
newsletter shares a new screening strategy. Learn more about it here
Zacks.com is a property of Zacks Investment Research, Inc., which was formed
in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find
patterns in stock market data that would lead to superior investment results.
Amongst his many accomplishments was the formation of his proprietary stock
picking system; the Zacks Rank, which continues to outperform the market by
nearly a 3 to 1 margin. The best way to unlock the profitable stock
recommendations and market insights of Zacks Investment Research is through
our free daily email newsletter; Profit from the Pros. In short, it's your
steady flow of Profitable ideas GUARANTEED to be worth your time! Register for
your free subscription to Profit from the Pros http://at.zacks.com/?id=113
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook:
Zacks Investment Research is under common control with affiliated entities
(including a broker-dealer and an investment adviser), which may engage in
transactions involving the foregoing securities for the clients of such
Visit http://www.zacks.com/performance for information about the performance
numbers displayed in this press release.
Disclaimer: Past performance does not guarantee future results. Investors
should always research companies and securities before making any investments.
Nothing herein should be construed as an offer or solicitation to buy or sell
Contact: Jim GiaquintoCompany: Zacks.comPhone: 312-265-9268Email:
SOURCE Zacks Investment Research, Inc.
Contact: Jim Giaquinto of Zacks Investment Research, Inc., +1-312-265-9268,
Press spacebar to pause and continue. Press esc to stop.